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Hexavalent chromium (Cr(VI)). a commonly used industrial metal, is a well known human lung
carcinogen. Epidemiology and animal studies suggest that the particulate Cr(VI) compounds,
specifically the water insoluble compounds., are the more potent carcinogens; however, the
carcinogenic mechanism remains unknown. Here we summarize recent Cr(Vl)-induced human
tumour, in vivo, cell culture and in vitro studies and put the data into context with three major
paradigms of carcinogenesis: multistage carcinngenesis. }ienumic instahility., and epigenetic
modifications. Based on these studies, we propose a mechanism for chromate carcinogenesis that is
primarily driven by the genomic instability paradigm.
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Introdtiction/overview
For more than 100 years, numerous epidemiological
studies have been performed on workers exposed to
hexavalent chromium {Cr(Vl)) to determine its
carcinogenicity. Major studies pinpointing Cr(VI) as a
human lung carcinogen have been performed on workers
involved in chromate production, chromate pigment
production and chromium plating. Chromate production
involves combining trivalent chromite ore with soda ash
and sotnetimes lime and heating the mixture to high
temperatures causing the chromite to oxidize to soluble
sodium chromate. If lime is used in the production
process, insoluble calcium chromate is also produced.
The first epidemiology study on chromate production
workers was performed in 1948. Machle and Gregorius
showed that 21.8 per cent of the chromate workers deaths
were due to respiratory cancer compared to only 1.4 per
cent in their reference population'. Large studies on
chromate production workers have also been performed
in Baltimore, Maryland; Plainsville, Ohio; and Great
Britain-\ Altogether, these studies indicate that these
workers have about a 2-80 fold increased relative risk of
developing lung cancer and that exposure to CriVl) and
not Cr(III) was responsible for this effect^  ''. Lung cancer
risk also increased with exposure time. These studies
indicate that insoluble calcium chromate is more
carcinogenic than soluble sodium chromate because lung
cancer rates decreased after factories changed to a low
or no lime production process^.
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Chromate pigment production involves reacting
sodium chromate with zinc or lead to produce insoluble
zinc chromate and lead chromate, respectively. Zinc
chromate and lead chrotnate are the predominate
chromium compounds used in pigments but insoluble
barium and strontium chroinate can also be used. Studies
in these workers also found that insoluble chromate
exposure increases lung cancer risk and that such risks
increase with exposure time^'''•''.
Animal studies support the epidemiologic fmdings
including both the observations that chromate exposure
causes lung cancer and that the water insoluble
(particulate) compounds are the more potent
carcinogenic form. The majority of studies investigating
soluble Cr(VI) compounds administered through
inhalation, intrabronchial implantation, or intratracheal
instillation either showed no effect or small but non
significant increases in lung tumour formation''.
However, numerous studies investigating particulate
Cr(VI) compounds such as calcium chromate, strontium
chromate. lead chrotnate and zinc chromate observed
significant increases in lung tumours. For example.
Levy et aP showed that intrabronchial implantation of
soluble sodium chromate induced only 1 bronchial
carcinoma in 100 rats whereas intrabronehial
implantation of two different doses of strontium
chromate induced 43 and 62 broncbial carcinomas in
99 rats. They reported no increase in bronchial
carcinomas after intrabronehial implantation of
particulate lead chromate**, however, three studies
injecting lead chtomate either subcutaneously or
intramuscularly induced a significant increase in
sarcomas at the injection site indicating that this
compound is also a carcinogen^ ".
Cell culture data also indicate that the particulate
compounds have greater potency. Working with C3H/
IOTl/2 cells, Patierno et aV- showed that only
particulate lead chromate could induce neoplastic
transformation while soluble sodium chromate could
not. Thus, epidetniology, whole animal and cell culture
studies all indicate that the particulate compounds are
the most potent carcinogenic fortns of Cr(Vl) with
respect to lung cancer. Interestingly, recent work has
shown that soluble Cr(VI) adtninistered chronically in
drinking water can induce oral and intestinal tumours''.
Thus, it appears that while soluble Cr(VI) may only be
weakly carcinogenic to the lungs, it may pose a more
significant carcinogenic risk if ingested. Studies have
not been done of particulate Cr( VI) after oral exposure,
but given the low pH of the stomach, it is likely that
these exposures would ultimately become exposures to
soluble Cr(VI) as particulate chromâtes dissolve at low
pH. The focus of this review is on chromate-induced
lung cancers as the drinking water data are very recent
and no studies have been done to clarify the mechanism
for these tumours.
Characteristics of chromate-induced lung tumours
Human pathology studies show that Cr(VI) deposits
and persists at bronchial bifurcations where Cr(Vl)-
associated cancers occur'^ ' \ which is consistent with a
particulate chromate exposure. The majority of lung
cancers in chromate exposed workers are squamous cell
carcinomas, often with multiple tumours'\ In addition,
chromium levels in workers with lung cancer are much
higher than in workers without lung cancer'^
Interestingly, one study found no correlation between
chromium accumulation in the lungs of workers and
duration of chromium exposure or multiple lung
tumours but malignancy stage was significantly
associated with chromium accumulation"'. The
association between malignant stage and chromium
accumulation was also confirmed in animal studies
where a pellet of strontium ehromate was inserted into
the bronchus of rats'^
Molecular studies of chromate-induced lung
tumours reveal that the tumours exhibit minimal
mutations in key oncogenes and tumour suppressor
genes but do exhibit genomic instability and epigenetic
changes {Table I). For example, there were no
significant differences in Bcl-2 and p53 expression
between lung tumours from chromate workers,
unexposed individuals and individuals with
pneumoconiosis"*. Few /?53 mutations and no ras
mutations were observed in tumours from chromate
warkers'**^". By contrast, these tumours exhibited both
chromosome in.stability (CIN) and microsattelite
instability (MIN). Hirose et al-^ found a statistically
significant increase in microsatellite instability. Of 38
chromate-induced lung tumours analyzed. 30 exhibited
instability in two or tnore microsatellite markers (79%)
while MIN was observed in only 4 of 26 tumours from
non-exposed individuals (15%)-'-^. MIN also
increased with lotiger exposure titne-' and was strongly
correlated with decreased expression of hMLH 1 -'. But
interestingly, MIN was not significantly associated
with hMSH2 repression''. In fact, 100 per cent of the
tutnours without MIN had repressed hMSH2
expression, while only 60 per cent of the tumours with
extensive MIN exhibited hMSH2 repression. In
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Table I. Characterization of Cr-induced tumours
Study population Assay Summary of findings Ref
19 lung tumours from 18 chromate-
exposed workers
Unexposed with lung cancer
Individuals with pneumoconiosis
20 lung tumours from 19 chromate-
exposed workers
38 lung; tumours from 32 workers
38 lung tumours from 28 ehromate-
cx posed workers
26 lung tumours from individuals
without chromate exposure
35 lung tumours from 26 chromate-
exposed workers
26 lung tumours from individuals
without chromate exposure
10 lung tumour specimens from
chromate workers
90 biopsy specimens from 25
chromate workers
38 lung tumours from 31 chromate
workers
40 lung tumours from 40 non-exposed
individuals
31 lung tumours from 26 chromate
workers
38 adenocarcinomas
from non-exposed individuals
46 s e c from non-exposed
individuals
89 healthy individuals
Immunohistochemistry
forcyclin Dl, bcl-2, p53
PCR-SSCP analysis
PCR-SSCP analysis
Analyzed six microsatellite
instability markers
Immunohistochemistry for
MLHI and MSH2
COBRA for MLH¡ promotor
methylation
Microsatellite instability
analysis
Microscopic X-ray fluorescence
analyzer with transmitted
X-ray mapping imaging
Methylation-specific PCR for
p¡6 promoter
Immunohistocbemistry for pI6
PCR genotyping methods for
SP-B intron-4 polymorphisms
Cyclin Dl expression significantly increased iti 18
chromate workers
Bcl-2 and p53 expression not significantly
different from controls
20% of chromate-induced tumours had p53 point 19
mutations
Fewer p53 mutations in chromate-induced tumours
than in lung tumours without chromate exposure
No association between mutations and length
of chromate exposure
No point mutations in ras observed in chromate 20
cancers.
RER statistically higher in chromate vs. non- 21
chromate lung cancer
No significant difference in frequency of
LOH but LOH frequency still 50-70%
Period of chromate exposure in workers
with RER were longer than those without RER
Workers with longer exposures to Cr(VI) had
higher frequency of MIN
Chromate-induced tumours showed a statistically 22
significant decrease in expression of bMSH2 and
hMLHl compared to non-chromate lung cancer
Only tbe repression rate for hMLHl was
significantly correlated to MIN
62.5% of the chromate lung cancer exhibited
hMLHl gene methylation
No correlation between chromium accumulation 16
and chromate exposure. MIN, smoking index or
presence of multiple lung carcinoma
Amount of chromium accumulation significantly
increased according to progression of malignancy
85.7% of chromate lung cancers had decreased pl6 23
expression
Workers with less than 15 years chromate
exposure had no p¡6 methylation but workers with
greater than 15 years exposure had higher levels
of pl6 methylation
Reduced pl6 expression was correlated with
methylation at p/6
SP-fí variations were significantly higher in 24
chromate workers with lung cancer compared to
unexposed individuals with lung cancer or healthy
individuals
addition, MIN was not significantly associated with
chromium accumulation in the íung'^. These data
suggest there may be a mechanism for MIN that does
not involve loss of mismatch repair function. Hirose
et aP' also found between 50-75 per cent loss of
heterozygosity (LOH) in 6 different loci they
examined, however, it was not significantly different
compared to tumours without chromate exposure. The
lack of statistical significance may suggest that LOH
is required for all lung cancers as previous studies have
shown that most lung cancers exhibit chromosome
instability^^.
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Chromate-induced tumours also exhibited changes
in gene expression of cyclin Dl and pl6'^-\ Cyclin
Dl expression was signiticantiy increased in chromate-
induced tumours but was not observed in the normal
epithelia adjacent to the tutTlour'^ P16 expression was
decreased in 86.7 per cent of chromate-induced lung
tumours which was associated with promoter
methylation-\ PI6 promoter methyiation was linked
to exposure time with tnethylation at the promoter only
found in workers exposed to chrotnate for 15 or tnore
years~\ Another study investigated variations in the
surfactant protein B (SP-B) gene. Removal of foreign
objects, such as chromate particles, from the upper
respiratory tracts requires SP-B and gene variations
in SP-B could enhance worker's susceptibility to
chromate lung cancer-^. Ewis et af'^ found that there
was a significant increase in insertion or delelion
variations in the SP-B gene in workers with chromate-
induced lung tumours compared to unexposed
individuals and chromate workers without lung
cancer^".
Potential mechanisms of chromate-induced
carcinogenesis
The mechanism of chromate-induced
carcinogenesis remains unknown. Three well-accepted
general paradigms of carcinogenesis include multistage
carcinogenesis. genomic instability, and epigenetic
modification. Using these three paradigms, we
summarize how data collected over the past seven years
support or refute these as tnodeis for chiomatc-induced
carcinogenesis.
Multi-stage carcinogenesis
Muhistage carcinogenesis is a tnuitistep process
which involves a series of cellular and molecular
changes, as a result of the progressive accumulation of
tnutations and alterations in protooncogenes and tumour
suppressor genes-*". Thus, for a chetnical to have a
carcinogenic mechanism that follows this paradigm, it
must be capable of inducing a significant number of
mutations in target genes.
Only one study investigated Cr(VI)-induced
mutation frequency m vivo (Table II). This study used
the Big Blue transgenic mouse-'. The authors
administered soluble potassium dichromate via
intratracheal instillation and found increased mutation
frequency in the lung that was dose- and time-
dependent^\ The majority of mutations were G:C
targeted base substitutions with a few deletions^''.
Cell culture studies also show that Cr(Vl) can
induce mutations (Table II). Nurnerous studies using a
shuttle-vector tiiutagenesis assay found a concentration-
dependent increase in mutations after exposure to 10-
200 uM soluble Cr(VI)-^". In these studies a SV-40
based plasmid with the supF gene was treated
extracellularly with Cr(VI) and then transfected into
and replicated by a human fibroblast cell line
immortalized with SV-40. Mutant clones were then
.selected for with Escherichia coli. These studies found
that Cr( VI)-induced mutations were the result of Cr{III)-
DNA adducts and were not caused by reactive oxygen
species or short-lived Cr(V) and Cr(IV)
intermediates^"-^'. They also found that while Cr(III)
fonns both binary and ternary DNA adducts, it is the
ternary DNA adducts that are the most mutagenic and
these are generated within 15-60 tnin after exposure-**"'.
Further, they found that Cys-Cr(III)-DNA adducts and
ascorbate-Cr(lII)-DNA adducts were 5.3 and 31 times
more mutagenic than binary lesions, respectively-'*-'".
One study using cysteine as a reducing agent found that
single base substitutions of GC to AT or TA were the
predominant mutations'^ and another study using
ascorbate found a sitnilar level of base substitution and
deletion mutations^.
Three cell culture studies considered mutagenesis
in an existing cellular chromosomal locus (Table II).
One study investigating both soluble and particulate
Cr(VI) compounds found that both potassiutn chromate
(soluble) and bariutn chromate (particulate) induced
mutations in transgenic V79 cells containing the
bacterial gpt reporter gene. The mutation ftequency of
potassium chromate peaked at three-fold above
background, while the mutation frequency of bariutr)
chromate peaked at 3.5-fold'-. However, the
significance of this increased mutation frequency is
uncertain because statistical comparisons were
apparently not conducted. In contrast to the in vivo study.
30-50 per cent of the [nutations were deletions'^ The
second study found that the atnount of ascorbate present
in Chinese hatnster ovary cells plays a role in tnutation
frequency at the hprt locus'\ When cells containing 15
I^ M ascorbate were exposed to Cr(VI). there was no
increase in mutations but if the cells were preloaded
with 1.4 mM ascorbate the mutation frequency
increased Í9.2-fold after exposure to 40 i^M Cr(VI).
The third study found that exposure to 6 |uM sodium
chromate for 24 h in Chinese hamster ovary cells
induced a 3.5-fold increase in mutation frequency and
mutation frequency was attenuated in cells deficient in
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Table II. Chromium (VI) - induced mutations
Treatment Assay (s) Model sy.slem Summary of effects Ref
Potassium dichromate
1.7-6.75 mg/kg
Intratracbeai instillation
Potassium chromate
10-100 fiM
1 h
2 mM cysteine
Lad gene mutagenesis assay
Potassium chromate
25-200 |JM
1 h
2 mM cysteine
S(xlium chromate
10-200,jiM
30 min
I mM ascorbate
Potassium chromate
25-200 |iM
1 h
0.2-1 mM ascorbate
Potassium chromate
5-50 \xU
2h
Barium chromate
0.05-0.25 Mg/cm=
24 h
Potassium chromate
0-40 MM
1 6h
15 |JM or 1.4 niM
ascorbate
Sodium chromate
0-6 (iM
24 h
Shuttle vector mutagenesis
assay
Shuttle vector mutagenesis
assay
Shuttle vector mutagenesis
assay
Shuttle vector mutagenesis
assay
Generation of gpt-
mutants, PCR for deletions
hpri mutagenesis assay
hprt mutagenesis assay
C57BL/6 Big Dose and time-dependent increase in mutation 27
Blue transgenic frequency in the mouse lung (4.2 fold increase
mice after 4 wk)
- 64% G:C to A:T transitions
- 26% G:C to T:A transversions
- few deletions
GSH depletion decreased mutant frequency
Cr-treated Concentration-dependent increaxSe in mutations 28
plasmids in Cr(III)-DNA adducts and not oxidative damage
HF/SV cells were responsible for mutations
Highest mutagenic lesions occurred 15-60 min
after exposure
Cy.s-Cr(III)-DNA adducts were more mutagenic
than binary CrdlO-DNA adducts
Single base substitutions were most prevalent
mutations
Cr-treated Cr-DNA adducts induced mutations 29
plasmids in Adducts arrest replication
HF/SV cells
Cr-treated Concentration-dependent increase in mutations 30
plasmids in and replication-blocking lesions
HF/SV cells Ascorbate-Cr(IIl)-DNA lesions were more
mutagenic and more efficient at inhibiting
replication than binary lesions
Similar number of base substitutions and
deletions
Cr-treated Concentration-dependent increase in 31
plasmids in mutations
HF/SV cells Increased stability of Cr intermediates
decreased mutation frequency and did not
induce the formation of more potent
mutation-inducing lesions
Transgenic, 3 fold increase in mutation frequency at a 32
V79 derived, dose that induced 40% survival
cell line (G12) -50% complete gpt deletions
3.5-fold increase in mutation frequency at
a dose that induced 75% survival
~30% complete gpt deletions
CHO and V79 No mutations observed in cells not pre-loaded 33
cells ^ with ascorbate
Preloading with ascorbate induced a concentration-
dependent increase in mutations at the hprt locus
CHO ceils: Concentration-dependent increase in mutation 34
AA8 frequency with 6 pM inducing a 3.5 fold
UV-5 (XPD-) increase in mutation frequency
UV-41 (XPF-) NER-deficient cells showed attenuated
mutagenesis
nucleotide excision repair (NER)^^ These data suggest
that proficietit NER is required for the induction of
tnutations after Cr(VI) exposure.
Considered together, these studies suggest that
Cr(VI) induces mutations, specifically targeting G:C
base substitutions. However, the data concerning
Cr(VI)-induced deletion mutations are inconsistent. The
in vivo study using the Big Blue transgenic mouse found
few deletion mutations, however, the Big Blue mouse
system is insensitive to these types of mutations". The
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inconsistency in the in vitro data may be due to the
different reducing agents used in the experiments. The
studies that used cysteine as a reducing agent observed
few deletion mutations while the studies that used
ascorbate observed comparable numbers of deletion and
substitution mutations. In addition, the one cell culture
experiment that investigated mutation spectrum found
that Cr(VI) induced 30-50 per cent deletion mutations.
Thus, Cr(VI) appears to induce deletion mutations
except when cysteine is the sole reducing agent.
Interestingly, the data for Cr(VT)-induced tumours
appear to contradict the whole animal and cell culture
studies. Mutations appear to be infrequent in chromate-
induced tumours, though these can be experimentally
induced. This discrepancy may indicate that Cr(VI) is
only weakly mutagenic, with mutations only occurring
at very high doses. Because ofthe technical challenges
of detecting mutations, experimental mutagenesis
studies often use very high doses that do not reflect
likely exposure scenarios. Indeed for the in vitro Cr( VI)
studies, the concentrations utilized were often between
25 and 200 [iM for short periods of time which is not
likely to be an environmentally or occupationally
relevant exposure. Exposing cells to this concentration
range would result in very little cell survival. For
example, exposure to 5 |aM sodium chromate for 24 h
induces close to 100 per cent cell death in human lung
fibroblasts""^''. Studies on CriVI)-induced toxicity in
human lung fibroblasts for shorter periods of time have
not been done, but only about 5 per cent of HCTl 16+ch3
cells (a human colon cancer cell line) survived a 3 h
treatment with 20 pM sodium chromate". In addition,
the majority of the mutation studies were performed
using a shuttle vector system, which does not fully
mimic the effects of Cr(VI) in a cell or the ability of
DNA repair systems to repair the damage. These
differences may contribute to the dramatically higher
mutation frequency in the shuttle vector mutagenesis
assays compared to the cellular chromosomal locus
mutagenesis assay and cause Cr(VI) to appear to be a
more potent mutagen in cell culture than it may actually
be.
The role of the reducing agent is an interesting
factor. The published data suggest that the levels of these
reducing agents can affect the mutation spectrum and
potency'""^'''. However, the full interpretation is
complicatedby limited data of the levelsof tbese agents
in human lung cells. For example, Reynolds et aP^ pre-
loaded cells with 1.4 mM ascorbate. This level is
comparable to ascorbate levels in freshly purified human
lymphocytes, however, these ascorbate levels are
dramatically higher than those reported in human lung
tissue. Specifically, in adults, lung tissue ascorbate
levels range from 0.045-0.065 mg/g which is
approximately 256 pM ascorbale'^. Reynolds et aP^
found that Cr(VI) increased mutation frequency only
occurred in cells preloaded with 1.4 mM ascorbate, a
level 5.5-times higher than human lung tissue levels.
Cr(VI) was not mutagenic in cells with ascorbate levels
lower than 1.4 mM. Thus, the reason mutation levels
were low in Cr(Vl)-induced human lung tumours may
be due to the fact that ascorbate levels in the lung are
not high enough for Cr( VI )-induced mutations to occur.
Such a conclusion would be consistent with the low
mutation rates in cell culture systems without ascorbate.
Lymphocytes, although high in ascorbate probably turn
over too quickly for mutalions to be expressed in vivo,
which likely explains the absence of significant
frequencies of Cr(VI)-induced cancer in these potential
target cells.
Interestingly, Reynolds et aP-^ found that CriVI) was
not mutagenic in cells without a high dose of ascorbate.
while both Klein et aP~ and Brooks et aP^ reported that
Cr(VI) was mutagenic in these cells. More specifically.
Klein el aP- found a 3-fold inctea.se in mutation frequency
at 40 |iM potassium chromate for 2 h while Reynolds
et aP^ found no increase in mutation frequency with the
same treatment for 3 h in cells that were not pre-loaded
with ascorbate. The discrepancy could be due to the
different cell lines used. Klein et aP~ used a CHO cell
line that contains the bacterial fipt reporter gene, while
Reynolds et aP^ used the endogenous hprt gene in CHO
cells to detect mutations. Therefore, the difference in
tnutation frequency could be due to differences in Cr( VI)-
induced mutations in exogenous versus endogenous
genes. However, Brooks et al^ used the same CHO eel!
line as Reynolds et aP^ and found a 3.5-fold increase in
mutations after a 24 h expcxsure to Cr( VI) as opposed to 3
h in Reynolds et al suggesting that Cr(VI) is mutagenic
without excess ascorbate. Given that two studies were
positive and the other negative, it seems likely that
ascorbate is not required for Cr(VI) mutagenesis, though
it may accelerate the process.
If Cr(VI) is indeed a weak mutagen, then the
mutation frequency that occurs after occupational
Cr(VI) exposure may not be high enough to induce
multiple mutations in key genes. For example, based
on the chromosotTial locus mutagenesis assay in cells
that were not loaded with high ascorbate, there was a
2-4 fold increase in mutation frequency above
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background"-^"*. Assuming that the spontaneous
mutation rate in dividing cells is 1.4 x 10 '" mutations
per base pair per cell generation and there are '-70,000
genes in the human genome, it is estitnated that only
one mutation would arise spontaneously in a normal
cells lifespan"'. Therefore, if Cr(VI) increases the.
normal mutation frequency by 2-4 fold, this would only
produce 2-4 mutations in a cell over its lifespan. The
likelihood of those 2-4 mutations randotniy mutating a
key tumour suppressor gene or oncogene seems low. In
addition, tumour suppressor genes often require
mutations in both alíeles in order to be inactivated
fuilher decreasing the probability of losing these genes.
On the other hand, it may be that the human tumour
studies have not considered enough genes and Cr(VI)
simply does not mutate p53 and ras. If this is true there
may be a higher mutation rate in other genes. This
possibility seems unlikely given that ras is mutated in
20-30 per cent of lung cancers*' and p53 is mutated in
50-90 per cent of lung cancers^'. These data would
suggest that Cr(VI)-induced tumours are unusual
compared to other lung tutnours.
The tnultistage carcinogenesis paradigm requires
the stepwise acquisition of mutations in multiple key
tumour suppressor and oncogenes. Considering the
above studies, it appears that Cr(VI) is not a potent
mutagen and is unlikely to induce sufficient mutations
for this paradigtn to apply. Therefore, we suggest that
the multistage carcinogenesis does not fit well for
chromate carcinogenesis.
Genomic instability
The genomic instability paradigm argues that
disruption of the control of genomic stability results in
a cascade of changes in the whole genome"*-. This
control can be disrupted by interfering with DNA repair,
kinetochore assembly, checkpoints, centrosome
duplication, microtubule dynatnics and numerous other
cellular maintenance processes^-'. In particular, there are
two types of genomic instability; tnicrosatellite
instability (MIN) and chromosome instability (CIN).
MIN is characterized by changes in the lengths of
microsatellites which are series of repetitive non-coding
DNA sequences that are abundant in the human
genome". DNA polymetases often slip while replicating
microsatellites resulting in insertion or deletion loops.
In normal cells, these insertion/deletion loops are
repaired by tnlsmatch repair (MMR). If cells acquire
defective MMR, they are unable to repair these lesions.
Unrepaired insertion/deletion loops result in changes
in the lengths of microsatellites which is carried through
to the whole genome increasing the mutation rate by
more than 20()-fold'\
MIN has been observed in Cr(VI)-induced
tumours''. Seventy nine per cent of the lung tumours
from chromate workers exhibited MIN at two or more
loci and 18 per cent of the tumours exhibited MIN at
all five markers tested-'. In contrast, only 15 per cent of
lung tumours from patients without Cr(VI) exposure
exhibited MIN at two or more loci-'. MIN was
associated with length of chromate exposure, with
workers with longer exposures exhibiting a higher
frequency of MIN- '^. MIN was also associated with
hMLH I repression-^. No animal studies or cell culture
studies have directly investigated the ability of Cr(VI)
to induce MIN so it is uncertain if these effects are early
or late events in tumourigenesis. This absence of data
is largely due to the absence of any sufficient m vivo or
in vitro tests for mismatch repair.
Two cell culture studies investigated the effects of
alterations in MMR gene expression. One study reported
that MMR-deficient carcinoma cells exhibited
decreased cytotoxicity, apoptosis and DNA double
strand breaks". In addition. MMR-deficient cells were
unable to induce replication arrest due to Cr-DNA
adducts". The second study reported that depletion of
MLHl or MSH2 in normal lung cells decreased the
formation of CREST(-) micronuclei and DNA double
strand breaks after potassium chromate exposure^^
These data suggest that proficient MMR plays a role in
Cr(VI)-induced genotoxicity and cytotoxicity. This
observation contrasts with the tumour data because
deficient MMR is required for MIN, while proftcient
MMR is required for double strand break fortnation
which may be a key step in the mechanism of Cr(VI)-
induced carcinogenesis.
CIN occurs in the majority of lung cancers and these
mmours can have both MIN and CIN'^ "*-*. CIN includes
both numerical and structural changes. Numerical CIN
involves the loss and gain of whole chromosomes.
Stmctural CIN involves chromosome translocations and
breaks. Exposure to Cr(VI) has been shown to induce
both numerical and structural CIN.
Numerical CIN has not been investigated in vivo
or in chromate-induced tumours. Using cell culture
models, five studies assessed numerical CIN after
Cr(VI) exposure by counting metaphase chromosomes
(Table Ilia). Two studies found that aneuploidy
increased in normal human lung ftbroblasts after a 30 h
360 INDIAN J MED RES. OCTOBER 2008
Table Ilia. Genomic instability: Microsatellite instability and numerical chromosome instability
Treatment Assay (s) Model system Summary of effects Ref
37Potassium dichromate
0-30 |iM
3h
Potassium chromate
0.2-5 fiM
1-6 h
1.4 mM ascorbate
Potassium dichromate
0.25-1 |JM
30 h
Potassium dichromate
0.25-1 pM
30 h
Lead chromate
0.1-1 pg/cm-
24-120 h
Lead chromate
0.1-1 Mg/cm^
24-120 h
Lead chromate
1-10 |jg/cm'
120 h
Clonogenic survival
Western blotting
Flow cytometry
H2A.X foci formation
H2A.X foci formation
Micronucleus assay
Chromosome counting
Chromosome counting
Anaphase-telophase assay
Chromosome counting
Clonogenic aneuploidy
Mitotic stage analysis
Centrosome analysis
Chromosome counting
Chromosome damage
Clonogenic aneuploidy
Mitotic stage analysis
Western blot for Mad2
expression
Transformation assay
Chromosome damage
Centrosome analysis
A549 human lung carcinoma
cells
Colon cancer cell lines:
HCTI16 (MLHI-/-)
DLDl (MSH6-/-)
HCT116-(-ch3 (MLH+)
DLDl+ch2 (MSH6+)
Mouse embryonic
fibroblasts: Mlh-/-,
Mlh+/+ Pms-A. Pm&+1+
IMR90 human lung
fibroblasts
MRC-5 human lung
fibroblasts
MRC 5 human lung
libroblasts
WTHBE-6 human lung
fibroblasts
WTHBF-6 human lung
fibroblasts
BEP2D human lung
epithelial cells
After Cr(VI) exposure, MMR-
deficient cells exhibited:
- increased clonogenic survival
- decreased apoptosis
- inability to block replication as a
result ol Cr-DNA adducts
- decreased DNA double strand
breaks
Depletion of MLHI or MSH2 33
decreased micronuclei and
double strand break formation
Increase in atieuploid cells 45
Increase in hypodiploid cells and
no increase in hyperdiploid cells
Increase in aneuploid cells, 46
specifically hypodiploid cells
Increase in chromatin bridges,
lagging chromosomes and lagging
fragments
Concentration- and time-dependent 17
increase in:
- aneuploid cells including
hypodiploid and polyploid cells
- centrosome number in both
interphase and mitotic cells
- abnormal mitotic figures including
disorganized anaphase and mitotic
catastrophe
Aneuploid cells were able to survive
and form colonies
Concentration- and time-dependent 48
increase in premature centromere
division, centromere spreading and
premature anaphase
Lead chromate disrupts mitotic
progression with an increase of cells
in anaphase
Decreased Mad2 expression
Time- and con centrat i on-dependent
increase in tetraploid cells and
tetraploid cells persist and form
colonies
SAC bypass due to chromium and
not lead ions or the particle
Chronic exposure to lead chromate 49
induced loss of contact inhibition
and anchorage-independent growth
Foci cells exhibited aneuploidy and
centrosome amplification
exposure to soluble chromate with a specific increase
in hypodiploid cells but no increase in hyperdiploid
.^g]|j,4.s.4f. j^Q studies found that chronic exposure to
particulate chromate induced concentration- and time-
dependent increases in aneuploidy in normal human
lung fibroblasts. However, in contrast to the soluble
chromate study, these studies reported increases in both
hypodiploid and tetraploid cells*'"" .^ These paniculate
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chromate-induced aneuploid cells were able to survive
and form colonies^^•''^ The fifth study showed that
hutnan lung epithelial cells transformed with lead
chromate also had increased aneuploidy further
indicating that the aneuploid phenotype persists'* .^
There are a number of mechanisms that can give
rise to nutnerical CIN. including centrosome
amplification, spindle assembly checkpoint bypass,
malfunctions in sister chromatid cohesion and
abnortnalities in kinetochore structure or function"*-.
Centrosome amplification can induce aneuploidy
through multipolar spindle formation and division*^".
Two studies considered centrosome amplification after
Cr(VI) exposure-"^-*". Holmes e! ¿//'^  reported a
concentration- and time-dependent increase in
centrosome amplification in hutnan lung fibtoblasts
exposed to particulate chromate. Centrosome
amplification was also observed in hutnan lung
epithelial cells transfonned by particulate chromate
indicating that centrosome amplification may be an
early event in Cr(VI)-induced carcinogenesis and that
this phenotype persists"" .^ One study considered spindle
assetnbly checkpoint bypass as a potential mechanism
of Cr(Vl)-induced aneuploidy"'^ This study reported
spindle assembly checkpoint bypass after chronic
particulate chromate exposure with concentration- and
titne-dependent increases in premature anapbase,
premature centrotnete division, centromere spreading
and the total number of cells in anapbase. In addition,
expression levels of Mad2, an important protein
involved in the regulation of tbe spindle assembly
checkpoint, were suppressed confirming spindle
assetnbly checkpoint bypass on a molecular level^^ This
study also showed that Cr(VI) and not the lead cation
or internalized particles were responsible for the spindle
assembly c'lcckpoint bypass^". The observed increase
in centromere spreading may also indicate that
chromium induces tnalfunction in sister chromatid
cohesion. Consistent with spindle assembly checkpoint
bypass and chromosome segregation malfunctions,
Seoane e¡ al.'*'' showed increased chromatin bridges,
lagging chromosomes and lagging fragments after a 30 h
soluble chromate exposure in human lung fibroblasts.
The induction of translocations is the gold standard
for evaluating and measuring structural CIN but so far
no studies have investigated the ability of Cr(VI) to
cause translocations. The tnajority of work investigating
structural chromosotnal effects bas considered the
induction of chrotnosomal aberrations which can lead
to structural CIN (Table Illb). Two different assays have
been used to assess chromosome damage: The
chromosome damage assay and the micronucleus assay.
Tbe chrotnosome damage assay is a more sensitive assay
and provides information on the kind of datnage fonned.
The micronucleus assay is less sensitive but is quicker.
A wealth of data using the chromosome damage assay
shows that both particulate and soluble Cr(Vl) induce
chromosomal aberrations in human lung fibroblasts and
human lung epithelial cells'^ " '^ •^ Furthermore, these
studies show that the lead cation and internalized
particles do not contribute to Cr(VI)-induced
clastogenicity and that ail of the effects are due to partial
dissolution of chromate particles releasing extracellular
Cr(VI).
I Tbree studies have investigated chromosome damage
in vivo using tbe micronucleus assay. The National
Toxicology Program (NTP) report. 2007 showed that
soluble chromate administered orally through drinking
water induced a concentration-dependent increase in
micronuclei in normochromatic erythrocytes in am3-
C57BL/6 male mice but only a small increase in
micronuciei in B6C3F| mice and no increase in BALB/c
mice^". A second study in tbe NTP report showed no
increase in tnicronuclei in normochrotnatic erythrocytes
after exposure to soluble chromate for 3 months through
drinking water in F344/N tats and B6C3F| mice '^'. The
third study showed that exposure to a single dose of
soluble chromate delivered by intraperitoneal injection
increased tnicronuclei frequency in polychromafic
eiytbrocytes in BDF, mice"".
The results from these in vivo studies are
inconsistent and bave some shortcomings in regard to
Cr(VI)-induced lung cancer, especially since the NTP
report was focused on the effects of Cr(VI) in drinking
water. First, these studies used soluble chromâtes and
administration routes that do not directly expose the
lung. In addition, the authors investigated micronuclei
fortnation in erythrocytes which are not the target cells
in chromate-induced lung tumours. One cell culture
based study using the micronucleus assay is consistent
with the chromosome damage studies confirming that
Cr(VI) induces chromosome aberrations". Even though
the in vivo data arc inconsistent, the cell culture data
clearly show that particulate and .soluble chtomate
induce chromosome damage in hutnan lung cells.
Cr(VI)-induced chromosome aberrations are most
likely caused by Cr(VI)-induced DNA double strand
breaks (Table IIIc). No in vivo studies have specifically
investigated double strand break formation. Several
recent cell culture studies demonstrated that both
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Table HI b. Genomic instability: Structural chromosome instability manifested as chromosome damage
Treatment Assay(s) Model system Summary of effects Ref
Lead chromate
0.1-5 )jg/cm-
24 h
Sodium chromate
I -10 pM
24 h
Lead chromate
0.1-5 |jg/cm-
24 h
Sodium chromate
1-10 MM
24 h
Lead chromate
0.1-5 |jg/cm'
24 b
Sodium chromate
1-5 (JM
24 h
Barium chromate
0.1-5 ng/cm-
24 h
Lead chromate
0.1-5 ^ig/cm'
24 h
Barium cbromate
0,1-5 pg/cnr
24 h
Lead chromate
0.1-5 jig/cm-
24 h
Sodium chromate
i-2.5 MM
24 h
Lead chromate
0.1-5 |ig/cm-
24 h
Lead chromate
0.1-1 Mg/cm-
24-72 h
Sodium chromate
0.5-2.5 (JM
24-72 h
Lead chromate
0.5-50 Mg/cm=
24 h
Sodium chromate
0.5-10 MM
24 b
Sodium dichromate
1.7-20.9 mg/kg in rats
3.1-27.9 mg/kg in mice
3 months orally
Sodium dichromate
2.8-8.7 mg/kg
3 months orally
Chromosome damage Primary human lung cells
Chromosome damage
Chromosome damage
Chromosome damage
Chromosome damage
Primary human lung cells
and WTHBF-6 human
lung fibroblasts
WTHBF-6 human lung
fibroblasts
WTHBF-6 human lung
fibroblasts
WTHBF-6 human lung
fibroblasts
Chromosome damage WTHBF-6 cells
Chromium particle uptake
Chromosome d:miage
Neutral comet assay
H2A,X (oci formation
Chromosome damage
WTHBF-6 human luni
fibroblasts
WTHBF-6 human lung
fibroblasts
Chromosome damage
Micronucleus assay
Micronucleus assay
BEP2D lung epithelial
celts
F344/N rats and
B6C3F, mice
B6C3F,, BALB/c.
and amJ-C57BL/6 mice
Lead chromate and sodium chromate 35
induced chromosome damage in a
concentration-dependent manner
Chromosome damage levels were 51
similar in primary human lung cells
and WTHBF-6 (hTERT-i-) cells
WTHBF-6 cells are as a useful
lung cell model
Cr(VI) is the proximate clastogen 52
Lead ions are not involved in the
clastogenicity of lead chromate
Barium chromate induced 53
concentration-dependent increases
in chromosome damage
Barium chromate was more genotoxic 54
than lead chromate
Chromosome damage was due to 55
external dissolution of lead chromate
particles
Particle-cell interaction was not
required for chromosome damage
induction
Concentration-dependent increase in 56
chromosome damage
Concentration-dependent increase
in DNA double strand breaks
ATM is phosphorylated in
response to DSB
Lead chromate induced a 57
concentration-dependent increase
in chromosome damage which
persisted over time
Sodium chromate-induced
chromosome damage decreased over
time
Lead chromate and sodium chromate 58
induced similar amounts and spectrum
of chromosome damage in human
lung epithelial cells
No increase in micronuclei in 59
normochromatic erythrocytes
Concentration-dependent increase in 59
micronuclei in normochromatic
erythrocytes in am3-C57B\J6 male mice
Conld....
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Treat menl Assay(s) Mode! system Summary of effects Rcf
Potassium dichromate
50 mg/kg i.p. injection
1 dose
Polassiunji chromate
0.2-5 MM
1-6 h
1.4 mM ascorbate
Micronucleus assay
Micronucleus assay
4ÜBDFI mice
IMR90 human lung
fibroblasts
Small (NS) increase in micronuclei in
B6C3F| mice and no increase in BALB/c mice
Increased frequency of micronuclei in 60
polychromatic erythfocytes
Preloading with ascorbate increased
CREST negative micronuclei
formation
Depletion of MLHl or MSH2
micronuclei
33
soluble and paniculate Cr{VI) induce DNA double
strand breaks measured by gamma-H2A.-X foci
formation or with the single cell gel electrophoresis
assay (comet assay)'-^-"-'*'''''" .^ These studies show that
the breaks only form during S and G2 phases as a result
of either excision repair of crosslinks/ternary adducts
or collapsed replication forks due to repeated cycles of
futile MMR attempting to repair these lesions'^ -^ '*-*\ In
addition, failure of homologous recombination repair
of DNA double strand breaks leads to more complex
and increased chromosome damage and neoplastic
transformation'^"'^ By contrast, failed NHEJ repair has
no effect on chromosomal aberrations''''.
The Cr(VI)-induced tumour and cell culture studies
show that Cr(VI) induces genomic instability but further
work needs to be performed to elucidate the specific
iiiechanism. Studies show that the Cr( VI ¡-induced tumours
exhibit MIN implying MMR inactivation. however, furtlier
work needs to be pertbrmed on the mechanism of MMR
inactivation. Current data suggest that proficient MMR is
required to produce double strand breaks and no studies
have demonstrated how or why Cr{VI) would target MMR
genes. Cell culture studies show that Cr(VI) induces
aneuploidy. centrosome amplification and spindle
assembly checkpoint bypass but these phenotypic changes
still need to be confirmed in the tumours. In addition, data
suggest that Cr(Vl) induces structural chromosome
instability because it induces chromosome damage and
DNA double strand breaks but this needs to be confirmed
by investigating the ability of Cr(VI) to induce
trans locations. However, considering all of the data, the
genomic instability paradigm is a possible model for
Cr(VI)-induced carcinogenesis.
Epigenetic modifications
Epigenetic modifications in cancer are changes in
cellular functions that occur without altering the genetic
material resulting in tumourigenesis''^. Examples of
epigenetic changes that could drive tumour formation
include altered DNA methylation or acetylation. protein
phosphorylation status changes, growth stimulation, and
altered gene expression or signaling pathways. Epigenetic
changes, including growth stimulation and enhanced
survival, changes in phosphorylation and methylation
status and altered gene expression and signaling
pathways, have been considered after Cr(VI) exposure.
Five recent studies have considered the potential role
of growth stimulation, escape from growth arrest and
apoptosis inhibition after Cr(VI) exposure. All were cell
culture studies (Table IVa). Two studies investigated the
hypothesis that the cation released from the partial
dissolution of particulate Cr(VI) compounds caused
Cr( VI) damaged cells to survive. These studies used lead
cbromate as a model compound in human lung fibroblasts
and found that lead did not promote survival of Cr( VI)-
damaged cells or stimulate the growth of Cr(VI)-damaged
cells"""*. Three studies investigated the hypothesis that
Cr(VI) could inhibit apoptosis. One study looked at direct
inhibition by soluble Cr(VI) in human lung epithelial
celis^^ It reported that soluble Cr(VI) induced NF-kB
activation which inhibited apoptosis possibly through the
inhibition of p53 activation* '^. Two studies considered
effects on apoptosis in cells tbat survived Cr(VI)
treatments™-^'. One study found that human skin
fibroblasts which survived a highly toxic dose of sodium
chromate were resistant to apoptosis and had at least a 2-
fold change in gene expression in genes involved in DNA
repair, apoptosis and cell cycle regulation'". Son et aP^
generated Cr(Vl)-resistant clones from human kidney
cells after three consecutive chromium trioxide
treatments. These clones were resistant to the cytotoxicity
of chromium trioxide and grew at a similar rate in media
containing high concentrations of chromium oxide as
cells in treatment-free media''.
Two studies investigated the potential effects of
Cr(VI) on phosphorylation (Table IVb). One was in cell
culture and the other was in vitro. The cell culture study
showed that tyrosine phosphorylation increased in a
364 INDIAN J MED RES. OCTOBER 2008
Table IIIc. Genomic instability: Structural instability manifested as DNA double strand breaks
Treatment Assay(s) Model system Summary of effects Ref
Potassium chromate
0.2-5 MM
1-6 h
1.4 mM ascorbate
H2A.X foci formation IMR90 human tung
fibroblasts
Potassium dichromate
0-30 \iM
3h
Lead chromate
0.1-5 [ig/cm^
24 h
Lead chromate
0.1-1 |ig/cm^
120 h
Sodium chromate
0-6 yM
1-24 h
Sodium chromate
3-6 |iM
1 o r3h
Potassium chromate
10-40 |iM
30 min - 24 h
Lead chromate
O.l-I fig/cm^
24 h
Lead chromate
0.1-10 Mg/cm'
24 h
H2A.X foci formation
Neutral comet assay
H2A.X foci formation
Transformation assay
Western blot
In vitro kinase assay
PS translocation assay
Cell growth analysis
Cell cycle analysis
Neutral comet assay
H2A.X foci formation
Cell cycle analysis
Comet assay
H2A.X foci formation
Flow cytometry
S-phase arrest
Chromosome damage
Chromosome damage
A549 lung carcinoma cells
Colon cell lines:
HCTII6 (MLH1-I-)
DLDl (MSH6-I-)
HCTl!6+ch3 ÍMLH+)
DLDI+ch2 (MSH6+)
Mouse embryonic
fibroblasts: Mlh-/-.
Mlh+/+ Pms-/-. Pms+/-*-
WTHBF-6 human lung
fibroblasts
WTHBF-6 human lung
fibroblasts
ATLD2 {Mrell-) human
skin fibroblasts
BJhTERT human skin
fibrobtasts
Normal human skin
fibroblasts
ATM null human skin
fibroblasts
Normal human skin
fibroblasts.
ATM-/- human skin
fibroblasts
SV40-immortalized human
skin fibroblasts from A-T
hétérozygote and from
A-T patient
HeLa cells
CH ovary cells: AA8 (WT)
irslSF (A-ffCCi-)lSFwt8
{XRCC3-\-)
CH lung cells: V79 (WT)
irs3(/ÍAD5/C-) irs3#6
(RAD51C+)
CH ovary cell:
CHO-Kl (WT),
xrs6 (Ku80-),
2E (Ku80+)
Preloading with ascorbate increased
H2A.X foci formation
Depletion of MLHl or MSH2
decreased double strand break
formation
Double strand break formation
occurred in S phase
Cr(Vl) induced DNA double strand breaks
Cells deficient in MMR exhibited
decreased DNA double strand breaks
33
37
Concentration-dependent increase in
DNA double strand breaks
ATM is pbosphorylated in response to
double strand breaks
Lead chromate induced loss of cell
contact inhibition and anchorage
independence in Mrel 1-deficient cells
ATM is activated after Cr exposure
and phosphorylates p53 at Sre-15
and Cbk2 at Thr-68.
ATM-deficient cells were resistant to
Cr apoptosis but exhibited a
prolonged growth arrest
Cr(V!) induced DNA double strand
breaks
Cr(VI)-induced DNA double
strand breaks are S phase-dependent
Cr(VI) induced DNA double strand
breaks
ATM is activated after exposure to
Cr and is required for S-phase
checkpoint activation
Cells deficient in RAD5IC or
XRCC3 exhibit increased
chromosome damage and ehromatid
exchanges after treatment
with lead chromate
Ku80-dcficicnt cells exhibit similar
levels of chromosome damage
compared to wild-type
55
61
62
63
64
65
66
time-dependent manner in human lung tumour cells after
exposure to 300 ^M Cr(VI) for 5-60 min^-. More
prolonged exposures reduced tyrosine phosphorylation
levels back to basal levels'^. The data suggest that the
increased phosphorylation was due to the production
of hydrogen peroxide and the hydroxyl radical during
the reduction of Cr(VI)''. The in vitro study also showed
that Cr(Vl) and Cr(V) induced phosphorylation by
facilitating the transfer of a phosphate to the hydroxyl
group of serine, threonine and tyrosine by alkali
hydrolysis^'. However, in contrast to the cell culture
study, this in vitro study showed that Cr(VI) and more
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efficiently Cr(V) induced the non-enzymatic
phosphorylation of bovine serum albumin
Studies pertbmied in Cr(VT)-induced tumours .showed
that methylation of the p 16 promoter increased with greater
than 15 years of exposure to chromate-' suggesting that
methylation may be an important mechanism for Cr(VI)-
induced lung cancer. Cr(Vl)-induced methylation has not
been considered in experimental animals. These effects
have not been considered in vivo. Only one cell culture
study has investigated the potential effects of Cr(VI) on
methylalion (Table IVb). It considered Cr(VI) eftects on
methylation in a transgenic Chinese hamster lung cell line
with a bacteria! gpt reporter gene. The study investigated
both particulate and soluble chromate and repotted partial
methylation in the gpt gene after soluble Cr( VI) exposure,
but no methylation changes after particulate Cr(VI)
exposure^-. These observations may reflect real differences
between the two types of chromate or altematively may
be related to exposure time as soluble chromate treatment
was only for 2 h while the barium chromate treatment was
for 24 h-'^
Three studies have utilized microarrays to
investigate gene expression changes after Cr(VI)
exposure (Table IVc). One study considered
expression in an in vivo model and evaluated the
expression of 56 genes in lung and liver tissue after 3
days of intratracheal instillation of soluble chromate
in male Sprague-Dawley rats^ .^ Genes induced in the
lung that are involved in Cr(VI) reduction, stress
response, apoptosis, cell cycle control and DNA repair
were altered. No changes were observed in the liver.
Two studies considered gene expression changes after
soluble chrotnate exposure in cultured cells. Ye and
Shi^^ found changes in genes involved in
carcinogenesis such as Src, MAPK and its related
proteins, cell cycle regulation, checkpoint suppressor
1. wnt-13 and carcinoma-associated antigen GA733-
2 after a 2 h exposure to 300 |AM soluble chromate in
human lung tumour cells. Andrew et aP" considered
1200 genes and found expression changes in 44 genes
after exposing itnmortalized hutnan lung epithelial
cells to lO^MCr(VI).
Table IVa. Epigenetic changes: Escape from growth arrest/apoptosis or growth stimulation
Treatment Assay(s) Model system Summary of effects Ref
Lead chromate
0.1-5 ^lg/cm'
24 h
Clonogenic
survival
WTHBF-6 human
lung fibroblasts
Sodium
1-10 l^
24 h
hromate
Lead chromate
0.1-5 fig/cm-
24 h
Sodium chromate
I -10 MM
24 h
Sodium dichrcmate
1-20 pM
36 h
Sodium chromate
1-9 fiM
4-24 h
Chromium trioxide
5-100 MM
1-7+ wk
Clonogenic
survival
Ciastogenicity
Growth curves
Cell cycle analysis
Mitotic index
Morphological
changes indicative
of apoptosis
PARP cleavage
TUNEL analysis
Phosphatidylserine
translocation assay
Clonogenic survival
Growth curves
Microarray
Generation of
resistant clones
Clonogenic survival
Growth curve
Toxicity analysis
curve
WTHBF-6 human
lung fibroblasts
BEAS-2B lung
epithelial cells:
IKK = normal NF-kB
activity; KM = low
NF-kB activity
BJ-hTERT derived
B-5Cr (ceils that
survived 99%
clonogenic lethality)
293 human kidney
cells
Lead ions do not promote Cr(VI)-damaged cells 36
to survive
Cr(Vl) ions are responsible for lead chromate-
indueed cytotoxicity
Lead ions do not stimulate Cr(VI)-damaged 68
cells to grow
Cr(VI) ions cause growth inhibition and arrest
Cr(VI) induced NF-kB activation 69
NF-kB activation prevented cells from
undergoing apoptosis
NF-kB deficient ceils activated p53 whiles
NF-kB proficient cells did not
B-5 Cr cells were resistant to apoptosis 70
and exhibited increased cionogenic survival
2 fold difference in regulation of genes involved
in DNA repair, apoptosis and cell cycle regulation
Generated Cr(VI)-resistant clones after consecutive 71
treatments with chromium trioxide
Cr(VI)-resistant cells grew at the same rate
regardless of whether chromium trioxide was present
or absent in the media
Resistance was specific to Cr(Vl)
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Table IVb. Epigenetic changes: Phosphorylation and methyiation changes
Treatment Assay{s) Model system Summary of effects Rcf
Potassium dichromate
300 MM
3-60 min
Potassium dichromale
Cr(V) species
100-500 pM
2niin- 18 h
Potassium chromate
5-50 |iM
2 h
Barium chromate
0.05-0.25 )jg/cm^
24 h
Western blot for
phosphotyrosine
expression
¡n vitro BSA
phosphorylation
Bovine serum albumin
+ radiolabeled ATP
Southern blot for the
detection of
methyiation variants
A549 human lung Time-dependent increase in tyrosine 72
carcinoma cells phosphorylation alter Cr{VI) exposure
Tyrosine phosphorylation is the result
of H,0, and OH radical production
Tyrosine phosphorylation returned
to basal level after prolonged exposure
Concentration-dependent non-enzymatic 73
phosphorylation of BSA by Cr(VI) and Cr(V)
Cr(V) compounds were more efficient
at phosphorylating BSA compared to Cr(VI)
Phosphate transferred by alkali
hydroly.sis to bydroxyl groups of serine/
threonine and tyrosine
Transgenic. V79 derived. Exposure to potassium chromate for 2 h 32
cell line (GI2) induced partial methyiation at gpt locus
Exposure to barium chromate for 24 h
induced no methyiation changes
Table IVc. Hpigenetic changes: Gene expre.ssion changes
Treatment Assay(s) Model system Summary of effects Ref
Sodium dichromate
1.25-2.5 mg/kg
intratracheal
instillation
3 days
Polassium
dichromate
300 |JM
2h
Sodium dicbromate
10 MM
4h
Microarray
Microarray
1200 gene nylon
array
Sprague-Dawley
rats
A549 human lung
carcinoma cells
BEAS-2B human
lung epithelia! cells
No change in gene expression in the liver 74
Expression of 56 genes increased in Jung after Cr exposure
Genes involved in Cr(VI) metabolism,
stress response, protein and DNA repair, signal
transduction. apoptosis and cell cycle regulation
were altered
Activation of genes involved in tumourigenesis 75
included NEN-I. cystatin M. carcinoma-associated
antigen GA733-2, breast tumour anti-antigen,
checkpoint suppressor I, wnt-13 and cytochrome
c-like polypeptide
Chromium altered the expression of 44 genes 76
Cbanges In mRNA expression induced changes
at the protein level
Alteration of cell sigtialing pathways is another
epigenetic mechanism. Three tnajor MAPK pathways
are the ERK, JNK and p38 pathway. These pathways
elicit a variety of responses depending on the activating
signals but they range from cell growth and proliferation
to apoptosis and differentiation. Many cell culture
studies have investigated the effects of Cr(Vl) on the
MAPK pathways (Table IVd). These effects have not
been considered in vivo. These studies found that JNK.
p38 and to a lesser degree ERK was activated in a
concentration and time-dependent manner by Cr(VTy'' "".
p38 and JNK were activated in response to oxidative
stress while ERK activation was not affected by
oxidative stress '^'. Activation of JNK, p38 and ERK were
not responsible for Cr(VI)-induced cytotoxicity and
therefore may promote cell survival and subsequently
carcinogenesis^"^ Another study investigating the
effects of lower levels of Cr(VI) on the JNK pathway
reveal that Cr(VI) and not reactive oxygen species
specifically activated JNK through the Lck/Fyn-Cas-
Crk signaling cascade; however., there was no
connection between JNK activation and
carcinogenesis**'. This study also showed that in addition
to activating JNK, Lck can also activate STAT3 which
induces the transactivation of IL-6. Activation of IL-6
for prolonged periods of time may induce chronic
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Table IVd. Epigenetic changes: MAPK and NFkB signaling
Treatment Assay(s) Model system Summary of effects Ref
Potassium
dicbromatc
10-80 MM
1-12 h
Potassium
dicbromate
10-80 nM
I - 1 2 li
Sodium
dichromate
10-80 )JM
I -12 h
Potassium
dicbromate
0.2-200 iiM
I h
Potassium
dicbromate
10 /JM
5-120 min
Potassium
dichromate
10 j-iM
1-72 h
Soluble
chromate
0.02-5
1 min -1
Potassiuni
dichromate
0.1-200 pM
3-16 h
Potassium
dichromate
12.5-800 MM
6 h
Lead chromate
10-50 ng/ml
0.5-12 h
Clonogenic survival
Kinase activity assay
CL3 non-small cell lung
carcinoma cells
MTT assay CL3 non-small cell lung
Clonogenic survival carcinoma cells
Annexin V apoptosis assay
Kinase activity assay
Western blot A549 human lung carcinoma
Co-immunoprecipitation cells
Western blot
Kinase activity assays
Western blot
Immunofluorescence
Mobility shift assay
Reporter gene activity
assay
Electrophoretic mobility
shift assay
Western blot
DNA fragmentation a.ssay
Non-radioactive ELISA
Electropboretic mobility
shift assay
Luciferase assay
for NF-kB and AP-1
Normal human small airway
epithelial cells
A549 human lung
carcinoma cells
BEAS-2B human lung
epithelial cells and primary
HBE cells
RAW264.7 mouse
macrophages and mouse
JB6 skin fibroblasts
BEAS-2B human lung
epithelial ceils and A549
hutnan lung carcinoma
cells
A549 human lung carcinoma
cells
RAW264.7 mouse
macrophages
Concentration- and time-dependent
increases in JNK, p38 and only small in
creases in ERK
p38 and JNK were induced in response to
oxidative stress while ERK was unaffected
by oxidative stress
Activation of JNK, p38 or ERK were not
responsible for Cr(VI)-induced cytotoxicity
Cr (Vl)-activated JNK was not involved in
apoptosis
ERK. JNK and p38 were not involved in
Cr (Vl)-induced cytotoxicity
Concentration- and time-dependent increase
in the activation of JNK and c-Jun
No increase in p38 activation
ASKl was activated by dissociation from its
regulatory partner and was responsible for JNK
activation
Increased activation of p38, JNK and ERK
Nontoxic doses of Cr(Vl) induced both
JNK and reactive oxygen species
Cr(VI) induced Fyn and Lck (but not Src and Cas)
and were required for JNK activation
Effects are specific to Cr(VI) and not due to ROS
Cr(VI) activated Lck inducing prolonged
activation of STAT3 and transactivation
of IL-6
Jak was not activated
77
78
79
80
81
82
83NF-kB and API activation was time-
and concentration-dependent
OH radical scavengers inhibited Cr(VI) activation
of NF-kB and AP-1
Inhibitors of p38 but not Erk reduced AP-1 activation
Concentration-dependent activation of 84
NF-kB and p53
Concentration-dependent decrease in cell
proliferation and increase in apoptosis
DNA binding of NF-kB increased in a
concentration- dependent manner
Reactive oxygen scavengers inhibited
NF-kB activation
NF-kB and AP-1 were activated by lead
chromate
85
86
inflammation and assist in the progression of lung
cancer*-. Hodges et aP'^ showed that JNK and c-Jun were
activated in a time-dependent manner after exposure to
sodium dichromate however, there was no effect on p38.
The authors also showed that ASKl was an upstreatn
activator of JNK I'"'. Studies suggest that NF-kB was
also activated by both soluble and particulate Cr(VI)
and it was activated in response to ROS via the p38
path way'^ "**^ . However, the activation of NF-kB may not
play a role in tuinourigenesis because activation of NF-
kB was associated with a decrease in cell proliferation
and an increase in
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Altogether these data show that chromate has the
ability to induce epigenetic changes. However, at this
time the consequences of these effects and their
impacts on Cr(VI)-carcinogenesis remain unknown.
For example, the effects on methylation may be
meaningful if they were to silence a gene like pi6 or
MLHl for lengthy periods of time while Cr causes
DNA damage and chromosome instability. On the other
hand, the effect on methylation may be merely
transient, as suggested by the soluble and particulate
data, and only occur briefly after the first couple hours
of exposure and have no long term effects. It is also
possible that some of these changes may inhibit tumour
progression rather than promote it. For example, the
activation of NF-kB may induce apoptosis rather than
cell survival. More research needs to be performed in
order to better elucidate the roles of epigenetic
modification in chromate-induced carcinogenesis.
Thus, epigenetic changes may have some importance
as a factor in Cr(VI) carcinogenesis, but given the
potency of Cr(VI) as a clastogenic agent and the
uncertain impact of the epigenetic changes, it does not
appear to be sufficient to explain Cr(VI)
carcinogenesis on its own.
Conclusion
Based on the recent chromate literature discussed
above, we suggest that the paradigm that best describes
chromate-induced lung cancer is genomic instability.
In the Fig., we propose a potential mechanism of
particulate chromate-induced carcinogenesis.
Specifically, particulate Cr(VI) (I) dissolves outside
the cell into the cbromate anion (2A) and cation (2C).
The cation enters into the cell via a channel protein
(3-4) and intact particles enter into the cell via
phagocytosis (2B) but both appear to have no
effect"^"". The chromate anion, on the other hand, is
the proximate genotoxic agent and enters into the cell
Crosslink Repair (CLR'l
Prlmirv CLR Pathway
NMiplMtIC
TranttormatlDn
•nd C«ncw
Cell Membrane
Fig. Proposed mechanism of Cr(VI)-induced carcinogenesis. Particulate CnVI) ( 1 ) partially dissolves outside the cell producing Ü chromate
anion (2A) and a cation (2C). The cation enters into the cell through a channel protein (3,4) and intact particles are phagocytosed into the
cell (2B), Both appear to have no adverse effect on the cell. The chromate anion enters the cell through an anion transporter (5) and is
rapidly reduced to Crdll) generating Cr(V). Cr(IV) and reactive oxygen species in the process (6). Crdll) and possibly Cr{V) and Cr(IV)
form ternary Cr-DNA adducts (7A} leading to a stalled DNA replication fork (81. These ternary adducts can be repaired by crosslink repair
involving nucleotide excision repair (9A) or mismatch repair (9B) or possibly both. Both pathways cause a DNA double strand break during
the repair process (10). The failure of base excision repair to repair oxidative damage could also contribute to DNA double strand break
formation, but this is likely to be a minor component as il requires failure of repair (7B, II). These DNA double strand breaks induce a
prolonged G2 arrest ( 12) leading to both centrosome amplification and spindle assembly checkpoint bypass ( 13). Centrosome amplification
and spindle assembly checkpoint bypass both lead io numerical chromosome instability (14) and ultimately neoplastic transformation and
cancer (17). The failure to properly repair the DNA double strand breaks (15) results in structural chromosome instability (16) which also
contributes to neoplastic transformation and cancer ( 17). Lastly, we propose that failure of mismatch repair ( 18) is the result of chromosome
instability and mismatch repair failure leads to microsatellite instability (19) which may also contribute to neoplastic transformation and
cancer (17). ('BER = Base excision repair; 'CLR = Crosslink repair: 'NER = Nucleotide excision repair; -"MMR = Mismatch repair; ^
= Double strand breaks; ''HR = Homologous recombination; 'SAC = Spindle assembly checkpoint).
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via an anión transporter (5)". Once inside the cell,
Cr(Vl) is rapidly reduced to Cr(III), forming Cr(V),
Cr{IV) and reactive oxygen species in the process {6f\
Cr(TII). as well as Cr(V) and Cr(lV), can form ternary
Cr-DNA adducts (7A) which lead to stalled DNA
replication forks (8)''-''. The Cr-DNA adducts can be
repaired through crosslink repair which involves
proficient nucleotide excision repair and results in a
DNA dottble strand break (9A-10)'\ Mismatch repair
also tries to repair Cr-DNA adducts but fails to repair
them and undergoes a series of futile repair cycles that
ultimately fail and collapse the replication fork also
leading to a DNA double strand break (9B-10)". A
third pathway in the formation of double strand breaks
could be the result of failure of base excision repair to
properly repair oxidative damage (7B, 11, 10). Next,
we propose that the DNA double strand breaks lead to
aG2arrest (12). With chronic exposure, this G2 arrest
becomes prolonged and induces both centrosome
amplification and spindle assembly checkpoint bypass
(I3J47.48 Centrosome amplification and spindle
assembly checkpoint bypass induce nurnericai
chromosome instability ultimately leading to
neoplastic transformation and cancer (14,17)'"^^ In
addition, misrepair of double strand breaks can cause
structural chromosome itistability also contributing to
neoplastic transformation and cancer (15-17)-*"'''.
Interestingly, chromate-induced tumours exhibit
MIN as well as CIN^', however, the formation of Cr(VT)-
induced DNA double strand breaks requires proficient,
lunctional MMR^\ Therefore, we propose that failure
of MMR leading to MIN is a later change in the cells
and probably a consequence of chromosome instability
(18-19).
Epigenetic changes and mutagenesis may contribute
to this carcinogenic mechanism. For example, the
activation of MAPK pathways may protTiote the survival
of cells with Cr(VI)-induced CIN or DNA methylation
may alter expression of genes and promote the growth
of cells with Cr(VI)-induced CIN into a tumour.
Mutagenesis tnay have some contribution if exposures
are high enough. A mutation in a gene itivolved in MMR
in the later stages of tumour progression could result in
the MIN phenotype observed in the tumours. DNA
methylalion of MMR genes could also contribute to
the later acquisition of the MIN phenotype. More work
is needed to understand how the epigenetic changes are
playing a role and if significant mutagenesis occurs in
relevant genes at likely exposure levels.
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